Cargando…
ST Elevations in the Era of COVID-19
Myocardial injury, represented by elevated cardiac enzymes, has been associated with increased morbidity and mortality in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections. Coronavirus disease 2019 (COVID-19) has created unique challenges in approaching patients with acute ST-s...
Autores principales: | Sang, Charlie Joseph, Heindl, Brittain, Von Mering, Gregory, Brott, Brigitta, Kopf, Robert S., Rajapreyar, Indranee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443235/ https://www.ncbi.nlm.nih.gov/pubmed/32855827 http://dx.doi.org/10.1155/2020/8845627 |
Ejemplares similares
-
Stress-Induced Cardiomyopathy Precipitated by COVID-19 and Influenza A Coinfection
por: Sang, Charlie Joseph, et al.
Publicado: (2020) -
Massive pulmonary embolism in a COVID-19 patient: a case report
por: Sang, Charlie J, et al.
Publicado: (2020) -
Cardiac pathology in COVID-19: a single center autopsy experience
por: Sang, Charlie J., et al.
Publicado: (2021) -
A Case of Heart Failure in a Patient With Systemic Lupus Erythematosus
por: Matos Santana, Heriberto, et al.
Publicado: (2020) -
The Value of Right Heart Catheterization: Case Series Showing Benefits in a Variety of Diagnoses
por: Ruge, Max, et al.
Publicado: (2023)